MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)

Phase 3
Completed
Conditions
Respiratory Distress Syndrome, Adult
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-03-23
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000579
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Baystate Medical Center, Springfield, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

Duke University, Durham, North Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

Wake Forest University, Winston-Salem, North Carolina, United States

and more 18 locations

Harvard Atherosclerosis Reversibility Project (HARP)

Phase 2
Completed
Conditions
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-03-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000461

Viral Activation Transfusion Study (VATS)

Not Applicable
Completed
Conditions
Acquired Immunodeficiency Syndrome
HIV Infections
Blood Transfusion
Cytomegalovirus Infections
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000593

Trial of Nonpharmacologic Interventions in Elderly (TONE)

Phase 3
Completed
Conditions
Hypertension
Cardiovascular Diseases
Heart Diseases
Vascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-11-06
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000535
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins University, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Bowman Gray School of Medicine, Winston-Salem, North Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Tennessee, Memphis, Tennessee, United States

and more 1 locations

Trial to Reduce Alloimmunization to Platelets (TRAP)

Phase 3
Completed
Conditions
Blood Platelets
Immunization
Hematologic Diseases
Blood Transfusion
Leukemia, Myelocytic, Acute
First Posted Date
1999-10-28
Last Posted Date
2016-11-06
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000589

Optimal Exercise Regimens for Persons at Increased Risk

Phase 2
Completed
Conditions
Coronary Disease
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2005-06-24
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000523

Raynaud's Treatment Study (RTS)

Phase 3
Completed
Conditions
Raynaud's Disease
Vascular Diseases
Cardiovascular Diseases
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-04-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000530

Studies of Left Ventricular Dysfunction (SOLVD)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Hypertension
Heart Failure
Myocardial Ischemia
Coronary Disease
First Posted Date
1999-10-28
Last Posted Date
2016-04-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000516

Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)

Phase 3
Completed
Conditions
Disease Transmission, Vertical
Acquired Immunodeficiency Syndrome
HIV Infections
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000590

Women's Angiographic Vitamin and Estrogen Trial (WAVE)

Phase 3
Completed
Conditions
Coronary Arteriosclerosis
Myocardial Ischemia
Postmenopause
Cardiovascular Diseases
Coronary Disease
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000555
ยฉ Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy